Optimizing Evidence-Reference-Cited by-同舟云学术

Optimizing Evidence

Published:2024-07-18 Issue: Volume: Page:209-223
ISSN:2327-7033
Container-title:Advances in Bioinformatics and Biomedical Engineering
language:
Short-container-title:

Author:

Osuolale Kazeem Adewale¹,Musa Adesola Zaidat¹,Falade Kazeem Iyanda²,Otekunrin Oluwaseun Aramide³,Osuolale Yusro Ayomide⁴,Shobanke Dolapo Abidemi⁵,Salako Abideen Olurotimi¹^ORCID

Affiliation:

1. Nigerian Institute of Medical Research, Nigeria

2. Dangote University, Kano, Nigeria

3. University of Ibadan, Nigeria

4. Federal University of Health Sciences, Nigeria

5. Federal University Lokoja, Nigeria

Abstract

Randomization stands as a pivotal component of clinical trial methodology, ensuring unbiased treatment allocation and robust study outcomes. However, its application raises significant ethical considerations that demand careful examination to uphold research ethics and safeguard participant rights. In this study, we explore the ethical implications of randomization in clinical trials, drawing insights from original references. Through a comprehensive analysis, we delineate key ethical issues surrounding randomization, including equitable treatment allocation, informed consent, participant autonomy, and the balance between scientific rigor and participant welfare. By elucidating these ethical dimensions, this study contributes to the ongoing discourse on research ethics and underscores the importance of ethical considerations in shaping the conduct and interpretation of clinical trials.

Publisher

IGI Global

Reference26 articles.

1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

2. Comparability of Randomised Groups

3. Treatment allocation by minimization.;D. G.Altman;British Medical Journal,1999

4. Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

5. FisherR. A. (1935). The Design of Experiments. Oliver and Boyd.